News & Analysis on Clinical Trial Services & Contract Research And Development
Hired and Retired: A wave of retirements
By Ben Hargreaves
- Last updated on
Organizations or individuals desiring change is often the reason for retirements, but the timing is often crucial and so it proved for two major institutions in the UK.
The UK’s MHRA and NICE are two of the most respected organizations when it comes to regulatory and the evaluation of effectiveness for treatments. However, both are now faced looking for new leadership ahead of any Brexit decision, after leadership retirements.
A similar story was seen in the industry itself, with Roche and Boehringer Ingelheim both losing some of its most experienced members of their leadership teams.